Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Nutr. hosp ; 39(2): 273-281, mar.- abr. 2022. tab
Artigo em Inglês | IBECS | ID: ibc-209694

RESUMO

Introduction: there are controversial data in relation to the reduction in body mass index standard deviation score (BMI-SDS) needed to improve adiposity in the pediatric population with obesity. The aim of this work was to determine the minimum variation in BMI-SDS required to improve the values of adiposity markers and cardiometabolic risk factors in growing adolescents with obesity. Methods: a longitudinal study consisting of clinical evaluation (waist circumference, waist-to-height ratio, fat mass index, and blood pressure) and blood testing (insulin resistance and lipid profile) was conducted in 350 adolescents with obesity (152 boys and 198 girls) aged 10.2-14.3 years who went through a combined intervention (12 months). Results: a decrease in SDS-BMI ≤ 0.5 was not associated with any significant improvement in the clinical features and blood testing recorded. A decrease in BMI-SDS > 0.5, and especially if > 1.0, was linked to a significant improvement in adiposity markers. A decrease in BMI-SDS > 0.5 was associated with a significant improvement in insulin resistance, and a decrease in BMI-SDS > 1.0 was associated with a significant decrease in the percentage of patients who showed high values of systolic blood pressure, HOMA-IR, and lipid profile Conclusions: improvement in body composition, insulin resistance, and lipid profile can be observed with reductions in BMI-SDS ≥ 0.5 in obese adolescents, while extended benefits are obtained by losing at least 1.0 BMI-SDS (AU)


Introducción: los datos en relación con la reducción del índice de masa corporal (IMC-SDS) necesario para mejorar la adiposidad en la población pediátrica con obesidad son controvertidos. El objetivo de este trabajo es determinar la variación mínima del IMC-SDS necesaria para mejorar los valores de los marcadores de adiposidad y los factores de riesgo cardiometabólico en adolescentes obesos. Métodos: estudio longitudinal clínico (perímetro de cintura, índice cintura-estatura e índice de masa grasa y presión arterial) y analítico (HOMA-R y perfil lipídico) realizado en 350 adolescentes con obesidad (152 niños y 198 niñas) de entre 10,2 y 14,3 años de edad que completaron una intervención combinada (12 meses). Resultados: una disminución en el índice de masa corporal (SDS-BMI) ≤ 0,5 no se asoció con ninguna mejora significativa de las características clínicas y analíticas registradas. Una disminución del IMC-SDS > 0,5, y especialmente si > 1,0, se relacionó con una mejora significativa de los marcadores clínicos de adiposidad. Una disminución del IMC-SDS > 0,5 se asoció con una mejora significativa de la resistencia a la insulina y una disminución del BMI-SDS > 1,0 se asoció con una disminución significativa del porcentaje de pacientes que mostraban valores altos de presión arterial sistólica, HOMA-IR y perfil lipídico Conclusiones: con una reducción del IMC-SDS ≥ 0,5 se observa una mejoría tanto en la composición corporal como en los factores de riesgo cardiovascular en los adolescentes obesos; no obstante, estos beneficios son mayores si la reducción del IMC-SDS es superior a 1.0 (AU)


Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Doenças Cardiovasculares/etiologia , Obesidade Infantil/complicações , Resistência à Insulina , Estudos Longitudinais , Fatores de Risco , Composição Corporal , Índice de Massa Corporal , Circunferência da Cintura
2.
J Endocrinol Invest ; 43(10): 1485-1492, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32215862

RESUMO

PURPOSE: To analyze whether vitamin D deficiency could condition the growth response to GH therapy, as well as to analyze if GH treatment modifies both seasonal variations and vitamin D levels in these patients. METHODS: Retrospective study in 98 prepubertal children with GH deficiency (GHD), aged 4.1-8.9 years treated with GH. Growth rate and blood testing (calcium, phosphorus, IGF-I, 25(0H)D and PTH) were monitored at diagnostic and every six months until 24 months of treatment. A control group was recruited (247 healthy children, aged 3.8-9.7 years). The criteria of the US Endocrine Society were used for the definition of hypovitaminosis D. RESULTS: There were no significant differences in vitamin D deficiency among control (12.5%) and GHD groups (15.3%) before starting treatment. Growth rate and IGF-1 and PTH increased (p < 0.05) during GH treatment, but there were no significant differences in calcium, phosphorus and 25(OH)D. There were no significant differences in growth rate and IGF-1, calcium and phosphorus levels in relation to the seasons along GH treatment. There was no correlation between 25(OH)D and IGF-1 during GH therapy. In every programmed control, patients with vitamin D deficiency showed lower growth rate (p < 0.05) compared to patients with vitamin D insufficiency or sufficiency. CONCLUSION: GH treatment, at least during the first two years, does not modify the vitamin D levels. Vitamin D deficiency could condition the response to GH therapy so vitamin D monitoring should be considered as part of the routine evaluation of children with GH treatment.


Assuntos
Transtornos do Crescimento/sangue , Transtornos do Crescimento/tratamento farmacológico , Hormônio do Crescimento Humano/uso terapêutico , Vitamina D/sangue , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Seguimentos , Transtornos do Crescimento/epidemiologia , Terapia de Reposição Hormonal , Hormônio do Crescimento Humano/deficiência , Humanos , Masculino , Puberdade/fisiologia , Estudos Retrospectivos , Resultado do Tratamento , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/epidemiologia
3.
Rev Sanid Hig Publica (Madr) ; 63(1-2): 63-70, 1989.
Artigo em Espanhol | MEDLINE | ID: mdl-2534647

RESUMO

This investigations is carried out order to find out the caries prevalence in a population affected by the Down syndrome. The rates obtained to fulfill this objective were CAOD and CAOS for the permanent dentition, and COD and COS for the temporary one. A total of 95 pupils between 6 and 21 years old were examined. 3 groups according to the age were established: the first one between 6 and 8 years old, the one between 9 and 13 years old and the third one between 14 and 21 years old. The following percentages were set for each age group and for boys and girls separately: Carious surfaces in permanent dentition, carious surfaces in temporal dentition, obturated surfaces in permanent dentition, obturated surfaces in temporal dentition and missing surfaces. The results indicate that the caries prevalence in these patients is similar to that obtained in other studies. Nevertheless, the number of obturations found is much smaller.


Assuntos
Índice CPO , Cárie Dentária/complicações , Adolescente , Adulto , Criança , Estudos Transversais , Assistência Odontológica para a Pessoa com Deficiência , Síndrome de Down/complicações , Feminino , Humanos , Masculino , Obturação Retrógrada , Espanha/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...